首页> 外文期刊>BMC Anesthesiology >Comparison of the impact of propofol versus sevoflurane on early postoperative recovery in living donors after laparoscopic donor nephrectomy: a prospective randomized controlled study
【24h】

Comparison of the impact of propofol versus sevoflurane on early postoperative recovery in living donors after laparoscopic donor nephrectomy: a prospective randomized controlled study

机译:腹腔镜供体肾病术后六氟醚对七氟醚对术后早期回收的影响:预期随机对照研究

获取原文
           

摘要

Enhancing postoperative recovery of the donor is important to encourage living kidney donation. We investigated the effects of anesthetic agents (intravenous [IV] propofol versus inhaled [IH] sevoflurane) on the quality of early recovery of healthy living kidney donors after hand-assisted laparoscopic nephrectomy (HALN) under analgesic intrathecal morphine injection. This single-center, prospective randomized controlled study enrolled 80 living donors undergoing HALN from October 2019 to June 2020 at Seoul St. Mary’s Hospital. Donors were randomly assigned to the IV propofol group or IH sevoflurane group. To measure the quality of recovery, we used the Korean version of the Quality of Recovery-40 questionnaire (QoR-40?K) on postoperative day (POD) 1, and ambulation (success rate, number of footsteps) 6–12?h after surgery and on POD 1. The pain score for the wound site, IV opioid requirement, postoperative complications including incidences of nausea/vomiting, and length of in-hospital stay were also assessed. The global QoR-40?K score and all subscale scores (physical comfort, emotional state, physical independence, psychological support, and pain) were significantly higher in the IV propofol group than in the IH sevoflurane group. The numbers of footsteps at all time points were also higher in the IV propofol group. Donors in the IV propofol group had a lower incidence of nausea/vomiting, and a shorter hospitalization period. Total IV anesthesia with propofol led to better early postoperative recovery than that associated with IH sevoflurane. Clinical Research Information Service, Republic of Korea (approval number: KCT0004351 ) on October 18, 2019.
机译:提高捐助者的术后回收对于鼓励肾脏捐赠非常重要。我们调查了麻醉剂(静脉内[IV]异丙酚对吸入[IH]七氟醚)对健康腹腔镜肾膜炎(HALN)后健康生活肾脏供体的早期恢复质量的影响。该单中心预期随机对照研究注册了80岁于2019年10月至6月20日在首尔圣玛丽医院的40次留下的80名活捐赠者。将供体随机分配给IV异丙酚基或IH七氟脲基团。为了衡量恢复的质量,我们在术后日(Pod)1的韩国版本的恢复质量(QOR-40?k),和牵引(脚步数)6-12?h手术后和豆荚1.伤口位点的疼痛评分,IV阿片类药物要求,术后并发症包括恶心/呕吐的发生率,以及入院时间的长度。全球QOR-40?K分数和所有次要评分(物理舒适,情绪状态,物理独立,心理支持和疼痛)在IV类异丙酚组中显着高于IH七氟醚组。 IV异丙酚组的所有时间点的脚步度数也较高。 IV异丙酚组的供体具有较低的恶心/呕吐的发病率较低,住院时间较短。与异丙酚的总静脉内麻醉导致术后早期恢复比与IH七氟醚相关的术后早期恢复。 2019年10月18日,大韩民国(批准号码:KCT0004351)临床研究信息服务。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号